Under construction – not a live service

Skip to content

Frontlight Research

Institution

Andreas Sygros Hospital

Athens, GreeceWebsite

Also known as: Ανδρέας Συγγρός Νοσοκομείο

1running trial
1closed trial
2,009publications (OpenAlex)

Running trials

Active, not recruiting
A Safety Study of Ustekinumab in the Treatment of Pediatric Participants Aged 6 Years and Older With Moderate to Severe Plaque Psoriasis
NCT03218488· Janssen-Cilag International NV· Source

Closed trials

Completed
Effects of IL17/23 Inhibitors on Markers of Subclinical Atherosclerosis in Patients With Psoriasis
NCT07169682· National and Kapodistrian University of Athens· Source

Registry name variants (1)

Trial registries list this institution under these names. Each row is one registry entry: its address and the trials registered under it.

Andreas Sygros Hospital
Athens, 16121
2 trials
- NCT07169682Effects of IL17/23 Inhibitors on Markers of Subclinical Atherosclerosis in Patients With Psoriasis
- NCT03218488A Safety Study of Ustekinumab in the Treatment of Pediatric Participants Aged 6 Years and Older With Moderate to Severe Plaque Psoriasis

Conditions

Diseases this institution publishes on or runs trials for.

Hidradenitis suppurativa7 works · 0 trials

Institution data: ROR 022v32y85 (CC0-1.0)Updated 12 Nov 2026

Report an error

Under construction, not live – Andreas Sygros Hospital: trials and research groups – Frontlight Research